Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Ophthalmol. 2014 Jan;25(1):35-9. doi: 10.1097/ICU.0000000000000016.

Ultraviolet-blocking intraocular lenses: fact or fiction.

Author information

1
Weill Cornell Medical College, New York, New York, USA.

Abstract

PURPOSE OF REVIEW:

Ultraviolet-blocking intraocular lenses (IOLs) are used routinely in cataract surgery and are widely accepted. Blue-blocking IOLs, however, have been much debated since their inception. In this article, we will review the advantages and disadvantages of blue-blocking IOLs.

RECENT FINDINGS:

In experimental and animal studies, acute blue light exposure induces retinal damage and the use of blue-blocking IOLs lessens this damage. Many large epidemiologic studies have further investigated this relationship between blue light exposure and the development of age-related macular degeneration, and have shown conflicting results. Visual performance and circadian rhythm disturbances have also been explored in patients with blue-blocking IOLs; no significant negative effects have been shown.

SUMMARY:

The current literature on blue-blocking IOLs is contradictory. Studies have failed to conclusively prove that blue-blocking lenses provide photoprotection against age-related macular degeneration or cause any significant detrimental effects on visual function or circadian rhythms.

PMID:
24248095
DOI:
10.1097/ICU.0000000000000016
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins - Ovid Insights
    Loading ...
    Support Center